Sort by
- Business Ethics 101 for the Biotech Industry
Biotechnology companies face ethical challenges of two distinct types: bioethical challenges faced on account of the nature of work in the life sciences, and corporate ethical challenges on account of...
Citation: MacDonald, Chris. 2004. Business Ethics 101 for the Biotech Industry. BioDrugs 18 (2):71-77.
Areas of Interest: Corporate Governance, Corporate Social Responsibility, Health - Biotech
- Corporate Decisions about Labelling Genetically Modified Foods
This paper considers whether individual companies have an ethical obligation to label their Genetically Modified (GM) foods. GM foods and ingredients pervade grocery store shelves, despite the fact th...
Citation: MacDonald, Chris and Melissa Whellams. 2007. Corporate Decisions about Labelling Genetically Modified Foods. In Journal of Business Ethics 75(2): 181-189.
Areas of Interest: Consumer Issues - Consumer Rights, Corporate Social Responsibility, Health - Biotech, Public Policy - Regulation
- Corporate Ethics in the Life Sciences: Can Bioethics Help? Should It?
The advice offered by the American Society for Bioethics and Humanities and American Society for Law, Medicine and Ethics (ASBH/ASLME) Task Force report on Bioethics Consultation in the Private Sector...
Citation: MacDonald, Chris. 2005. Corporate Ethics in the Life Sciences: Can Bioethics Help? Should It? Healthcare Ethics Committee Forum 17 (2):122-134.
Areas of Interest: Health - Biotech
- Intellectual Property and Biotechnology: Biological Inventions
This book documents and evaluates the dramatic expansion of intellectual property law to accommodate various forms of biotechnology from micro-organisms, plants, and animals to human genes and stem cells. It makes a unique theoretical contribution to the controversial public debate over the commercialisation of biological inventions....
Citation: Rimmer, Matthew. 2008. Intellectual Property and Biotechnology: Biological Inventions. Cheltenham, UK, and Northampton, MA, USA: Edward Elgar. Available at SSRN: http://ssrn.com/abstract=1105541 and http://works.bepress.com/matthew_rimmer/22
Areas of Interest: Health - Biotech
- Myriad Genetics: In the Eye of a Policy Storm
From the late 1980s, a storm surrounding the wisdom, ethics and economics of human gene patents has been brewing. The various winds of concern in this storm touched on the impact of gene patents on basic and clinical research, on health care delivery, and on the ability of public health care systems to provide equal access when faced with costly patented genetic diagnostic tests. Myriad Genetics, Inc. along with its subsidiary, Myriad Genetic Laboratories, Inc., a small Utah-based biotechnology company, found itself unwittingly in the eye of this storm after a series of decisions it made regarding the commercialization of a hereditary breast cancer diagnostic test. This case study examine the background to Myriad's decisions, the context in which these decisions were made and the policy, research and business response to them....
Citation: Gold, Edward Richard and Carbone, Julia. 2008. Myriad Genetics: In the Eye of a Policy Storm (September 9). SSRN eLibrary. Available at: http://ssrn.com/abstract=1260098
Areas of Interest: Health - Biotech
- Risk Measures and the Cost of Equity in the New Economy Biotechnology Industry
The cost of equity is important in valuing new investment opportunities and in evaluating the ongoing performance of existing business projects. This is especially true in the new economy biotechnolog...
Citation: Henriques, Irene; Sadorsky, Perry. 2003. Risk Measures and the Cost of Equity in the New Economy Biotechnology Industry. Global Business and Economics Review 5 (1):37-55.
Areas of Interest: Health - Biotech, SRI/Responsible Investment
- Will the "Secular Priests" of Bioethics Work Among the Sinners?
In this paper, I explore briefly the "secular priesthood" metaphor often applied to bioethicists. I next ask: if, despite our discomfort with the metaphor, we were to embrace the best aspects of the p...
Citation: MacDonald, Chris. 2003. Will the "Secular Priests" of Bioethics Work Among the Sinners? American Journal of Bioethics 3 (2):W36-W39.
Areas of Interest: Health - Biotech
|